Why Autoimmune Diseases, Including Type 1 Diabetes, Affect More Women Than Men
Women are diagnosed with autoimmune diseases at much higher rates than men. New research explores how genetics, hormones, and pregnancy reshape the immune system in ways that may explain this difference.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Autoimmune diseases affect 5–10% of the population overall, but 80–85% of diagnoses occur in women
- Three main factors drive this difference: genes (particularly on the X chromosome), fluctuating sex hormones, and immune changes during pregnancy and after birth
- Pregnancy triggers unique immune shifts that can either improve or worsen autoimmune conditions, depending on the disease
- Understanding pregnancy's effects on the immune system may help explain why Type 1 diabetes and other autoimmune diseases follow different patterns in women
A striking gender gap in autoimmune disease
Autoimmune diseases—conditions in which the immune system attacks the body's own cells—affect roughly 5–10% of people worldwide. But there's a striking imbalance: women account for 80–85% of all diagnoses. This isn't random. Researchers have identified three main drivers: the genes we inherit, the sex hormones our bodies produce, and the profound immune changes that happen during pregnancy and in the months after birth.
Genes, hormones, and immune shifts
Women and men have different genetic blueprints when it comes to immune function. Women have two X chromosomes, while men have one X and one Y. The X chromosome carries many genes that regulate immune responses, which may give women a more robust—but sometimes overactive—immune system.
Sex hormones like estrogen also play a role. Hormone levels fluctuate throughout a woman's life: during the menstrual cycle, pregnancy, and menopause. These shifts can amplify or dampen immune responses in ways specific to each autoimmune disease.
Pregnancy rewires the immune system
Pregnancy represents one of the most dramatic immune events in a woman's life. The immune system must accept a genetically foreign fetus while still protecting against infection—a delicate balance achieved through specialized mechanisms at the placenta.
During and after pregnancy, the body experiences major immune remodeling. Some autoimmune diseases improve during pregnancy, while others worsen. This depends partly on whether the disease involves a Th1 response (more attack-oriented) or a Th2 response (more tolerance-oriented), and whether it targets specific organs or the whole body.
Additionally, fetal cells can persist in the mother's body long after birth—a phenomenon called fetal microchimerism. Research suggests this lingering fetal presence may influence how the maternal immune system behaves, potentially affecting disease risk and severity.
What this means for Type 1 diabetes and other conditions
Type 1 diabetes is one of several autoimmune diseases—alongside lupus, rheumatoid arthritis, and multiple sclerosis—that show very different patterns between women and men. Each disease responds differently to pregnancy and hormonal changes because they involve different immune mechanisms.
Understanding these pregnancy-related immune shifts offers clues about why women face higher overall autoimmune disease risk and why some conditions improve or worsen during and after pregnancy. This knowledge could inform how doctors monitor and support women with autoimmune diseases during their reproductive years.
Evidence label
Source: Immunologic research. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
From Type1Cure
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Research summaryCauses & What We KnowPregnant Women with Diabetes Show Higher Rates of Toxoplasma InfectionPubMed indexed literature
- Research summaryCauses & What We KnowExploring Rare Breast Inflammation: What BRCA Mutations and Type 1 Diabetes May SharePubMed indexed literature
- Research summaryCauses & What We KnowUnderstanding Type 1 Diabetes: A Shift Toward Early InterventionPubMed indexed literature
- Research summaryCauses & What We KnowHow Nutrition, Metabolism, and Immunity Connect: What the Lectin Pathway Tells UsPubMed indexed literature
- Research summaryCauses & What We KnowHow Gut Bacteria May Influence the Intestinal Barrier in Type 1 DiabetesPubMed indexed literature
- Research summaryCauses & What We KnowLiver Changes in Cystic Fibrosis: What a New Study FoundPubMed indexed literature